| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Chief Commercial Officer
1 company
Dierks Jeffrey is a Chief Commercial Officer at HRMY. Recent filings cover 0 purchases and 38 sales. Those positions are worth an estimated $192K at current prices.
Our model assigns Dierks Jeffrey a middling insider score of 62/100, based on 28 past trades. Over a 12-month horizon, 53.6% of those trades were profitable, with an average 12-month return of -1.5%.
Dierks Jeffrey's largest disclosed position is in HRMY as Chief Commercial Officer, worth about $192K. The recent filings there lean toward selling, a net 304,548 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 10,000 | $33.61 | $336,125.20 | -75.2% | -0.5% | +32.4% | |
| Aug 27, 2021 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $35.13 | $175,625.12 | -100% | +6.5% | +35.0% | |
| Jun 15, 2021 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 15,000 | $31.32 | $469,806.00 | -100% | +13.9% | +40.6% |